PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism-Reference-Cited by-同舟云学术

PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism

Published:2023-01 Issue:1 Volume:13 Page:157-173
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Sun Mingming,Li Leilei,Niu Yujia^ORCID,Wang Yingzhi,Yan Qi,Xie Fei,Qiao Yaya,Song Jiaqi,Sun Huanran^ORCID,Li Zhen^ORCID,Lai Sizhen,Chang Hongkai,Zhang Han,Wang Jiyan,Yang Chenxin,Zhao Huifang,Tan Junzhen,Li Yanping,Liu Shuangping,Lu Bin,Liu Min,Kong Guangyao,Zhao Yujun,Zhang Chunze^ORCID,Lin Shu-Hai,Luo Cheng,Zhang Shuai^ORCID,Shan Changliang^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference25 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma;Du;Acta Pharm Sin B,2022

3. Inhibition of 6-phosphogluconate dehydrogenase reverses cisplatin resistance in ovarian and lung cancer;Zheng;Front Pharmacol,2017

4. Post-translational modifications and the Warburg effect;Hitosugi;Oncogene,2014

5. Arginine methylation: the coming of age;Blanc;Mol Cell,2017

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the PRMT6 modulators in cancer treatment: Current progress and emerged opportunity;European Journal of Medicinal Chemistry;2024-12

2. Arginine methylation and respiratory disease;Translational Research;2024-10

3. Regulation of bacterial stringent response by an evolutionarily conserved ribosomal protein L11 methylation;mBio;2024-08-27

4. Algicidal bacteria-derived membrane vesicles as shuttles mediating cross-kingdom interactions between bacteria and algae;Science Advances;2024-08-09

5. METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1;Cancer Letters;2024-08